<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:Helvetica;
panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
{font-family:Wingdings;
panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:"Calibri Light";
panose-1:2 15 3 2 2 2 4 3 2 4;}
@font-face
{font-family:Verdana;
panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
{font-family:Aptos;}
@font-face
{font-family:"Segoe UI";
panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
font-size:11.0pt;
font-family:"Aptos",sans-serif;
mso-ligatures:standardcontextual;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#467886;
text-decoration:underline;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
{mso-style-priority:34;
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:.5in;
font-size:11.0pt;
font-family:"Aptos",sans-serif;
mso-ligatures:standardcontextual;}
span.EmailStyle20
{mso-style-type:personal-reply;
font-family:"Verdana",sans-serif;
font-variant:normal !important;
color:black;
text-transform:none;
font-weight:normal;
font-style:normal;
text-decoration:none none;
vertical-align:baseline;}
p.elementtoproof, li.elementtoproof, div.elementtoproof
{mso-style-name:elementtoproof;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:12.0pt;
font-family:"Aptos",sans-serif;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;
mso-ligatures:none;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:401756839;
mso-list-template-ids:559596962;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level2
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level3
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level4
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level5
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level6
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level7
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level8
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level9
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1
{mso-list-id:804471173;
mso-list-template-ids:2017501160;}
@list l1:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level2
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level3
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level4
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level5
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level6
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level7
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level8
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level9
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l2
{mso-list-id:1500543123;
mso-list-type:hybrid;
mso-list-template-ids:-648108054 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l2:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l2:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l2:level3
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
@list l2:level4
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l2:level5
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l2:level6
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
@list l2:level7
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l2:level8
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l2:level9
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
ol
{margin-bottom:0in;}
ul
{margin-bottom:0in;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="#467886" vlink="#96607D" style="word-wrap:break-word">
<div class="WordSection1">
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:"Verdana",sans-serif;color:black;mso-ligatures:none">Hello, HIV and STI Prevention partners,</span><span style="mso-ligatures:none"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:"Verdana",sans-serif;color:black;mso-ligatures:none"> </span><span style="mso-ligatures:none"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:"Verdana",sans-serif;color:black;mso-ligatures:none">Welcome to this week’s HIV/STI Prevention listserv email! Please email me at
</span><a href="mailto:shelley.m.pearson@oha.oregon.gov"><span style="font-size:12.0pt;font-family:"Verdana",sans-serif;mso-ligatures:none">shelley.m.pearson@oha.oregon.gov</span></a><span style="font-size:12.0pt;font-family:"Verdana",sans-serif;color:black;mso-ligatures:none">
with any feedback about the listserv, with announcements/resources to share, or if you have colleagues who would like to be added to the list. For more information about the resources shared, please reach out via the contact information on each item.
</span><span style="mso-ligatures:none"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:"Verdana",sans-serif;color:black;mso-ligatures:none"> </span><span style="mso-ligatures:none"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:"Verdana",sans-serif;color:black;mso-ligatures:none">In this week’s email (click on the title to jump to that item):<o:p></o:p></span></p>
<ul style="margin-top:0in" type="disc">
<li class="MsoListParagraph" style="color:black;margin-left:0in;mso-list:l2 level1 lfo3">
<span style="font-size:12.0pt;font-family:"Verdana",sans-serif"><a href="#samhsa">SAMHSA HCV Elimination Funding Opportunity due August 1, 2025 (informational webinar today)</a></span><span style="font-size:14.0pt;font-family:"Verdana",sans-serif;mso-ligatures:none"><o:p></o:p></span></li><li class="MsoListParagraph" style="color:black;margin-left:0in;mso-list:l2 level1 lfo3">
<span style="font-size:12.0pt;font-family:"Verdana",sans-serif;mso-ligatures:none"><a href="#nhahc">July 24 Webinar: NHAHC & NASTAD Drug User Health & Housing: Creating Low-Barrier Housing Solutions</a><o:p></o:p></span></li><li class="MsoListParagraph" style="color:black;margin-left:0in;mso-list:l2 level1 lfo3">
<span style="font-size:12.0pt;font-family:"Verdana",sans-serif;mso-ligatures:none"><a href="#naccho">STI/HIV Program Director Orientation for Rural Areas</a><o:p></o:p></span></li></ul>
<p class="MsoListParagraph"><span style="font-size:12.0pt;font-family:"Verdana",sans-serif;color:black;mso-ligatures:none"><o:p> </o:p></span></p>
<div class="MsoNormal" align="center" style="text-align:center"><span style="font-size:12.0pt;font-family:"Verdana",sans-serif;color:black">
<hr size="1" width="100%" align="center">
</span></div>
<p class="MsoNormal" align="center" style="text-align:center"><span style="font-size:14.0pt;font-family:"Verdana",sans-serif;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">SAMHSA has recently released a NOFO for a
</span><u><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:blue"><a href="https://www.samhsa.gov/grants/grant-announcements/ti-25-005">Hepatitis C Elimination Initiative Pilot</a></span></u><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black"> due
by <u>August 1, 2025</u>. There will be an informational webinar held <u>July 17, 2025 at 2:30 PM ET</u> and you can join at this
</span><u><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:blue"><a href="https://teams.microsoft.com/l/meetup-join/19%3ameeting_NGM3OTQxYzgtODgwOC00N2ZmLWFhMTgtNTNlODFkNzAzZjM4%40thread.v2/0?context=%7b%22Tid%22%3a%22d58addea-5053-4a80-8499-ba4d944910df%22%2c%22Oid%22%3a%22779c5b08-4888-4e5d-8b77-180c570b7022%22%7d">link</a></span></u><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black"> (Microsoft
Teams).</span><span style="font-size:14.0pt"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black"> </span><span style="font-size:14.0pt"><o:p></o:p></span></p>
<p class="MsoNormal"><a name="samhsa"></a><b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">Description:
</span></b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">The purpose of this proof-of-concept program is to leverage existing health care institutions’ capacity to prevent, test for, treat, and cure Hepatitis C (HCV) in individuals
with substance use disorder (SUD) and/or severe mental illness (SMI), particularly in communities severely affected by homelessness and to gain insights on effective ways to identify patients, complete treatment and reduce reinfection.</span><span style="font-size:14.0pt"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">Eligibility:
</span></b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">Eligible applicants are States and Territories, including the District of Columbia, political subdivisions of States, Indian tribes or tribal organizations (as such terms
are defined in section 5304 of title 25), health facilities, or programs operated by or in accordance with a contract or award with the Indian Health Service, or other public or private non-profit entities, including faith-based organizations.</span><span style="font-size:14.0pt"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">Award Information</span></b><span style="font-size:14.0pt"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">Funding Mechanism:</span></b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black"> Grant</span><span style="font-size:14.0pt"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">Anticipated Total Available Funding:</span></b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black"> $100,000,000</span><span style="font-size:14.0pt"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">Anticipated Number of Awards:</span></b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black"> 13-40 awards</span><span style="font-size:14.0pt"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">Anticipated Award Amount:</span></b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black"> Up to $2,500,000 - $7,500,000 per award for
the first 2 years (up to $1,250,000 - $3,750,000 per year)</span><span style="font-size:14.0pt"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">Length of Project:</span></b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black"> Up to 3 years</span><span style="font-size:14.0pt"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">Call Information</span></b><span style="font-size:14.0pt"><o:p></o:p></span></p>
<p class="elementtoproof" style="margin:0in"><span style="font-size:14.0pt;color:black">On July 17, 2025, at 2:30 p.m. EDT, the Substance Abuse and Mental Health Services Administration (SAMHSA) will hold a 60-minute webinar and conference call on a recently
released Notice of Funding Opportunity (NOFO) for a Hepatitis C Elimination Initiative Pilot (TI-25-005).</span><span style="font-size:16.0pt"><o:p></o:p></span></p>
<p class="elementtoproof" style="margin:0in"><span style="font-size:14.0pt;color:black"> </span><span style="font-size:16.0pt"><o:p></o:p></span></p>
<p class="elementtoproof" style="margin:0in"><span style="font-size:14.0pt;color:black">SAMHSA staff will lead the webinar, presenting on basic information related to the grant, such as the grant’s purpose, funding, length of the project, and time periods;
applicant eligibility criteria; application requirements; required and allowable activities; data collection and reporting; funding restrictions; application evaluation criteria; and contact information.</span><span style="font-size:16.0pt"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black"> </span><span style="font-size:14.0pt"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">2:30 p.m. to 3:30 p.m. EDT, July 17, 2025</span></b><span style="font-size:14.0pt"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">Link to meeting URL:</span></b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">
</span><u><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:#467886"><a href="https://teams.microsoft.com/l/meetup-join/19%3ameeting_NGM3OTQxYzgtODgwOC00N2ZmLWFhMTgtNTNlODFkNzAzZjM4%40thread.v2/0?context=%7b%22Tid%22%3a%22d58addea-5053-4a80-8499-ba4d944910df%22%2c%22Oid%22%3a%22779c5b08-4888-4e5d-8b77-180c570b7022%22%7d">https://teams.microsoft.com/l/meetup-join/19%3ameeting_NGM3OTQxYzgtODgwOC00N2ZmLWFhMTgtNTNlODFkNzAzZjM4%40thread.v2/0?context=%7b%22Tid%22%3a%22d58addea-5053-4a80-8499-ba4d944910df%22%2c%22Oid%22%3a%22779c5b08-4888-4e5d-8b77-180c570b7022%22%7d</a></span></u><span style="font-size:14.0pt"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black"> </span><span style="font-size:14.0pt"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">Meeting ID:
</span></b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">239 431 941 631 7</span><span style="font-size:14.0pt"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">Passcode:
</span></b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">LN7nY3o9</span><span style="font-size:14.0pt"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black"> </span><span style="font-size:14.0pt"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">Call-in information:</span></b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black"> +1 206-420-5032,,574682280#<br>
<b>Phone conference ID:</b> 574 682 280#</span><span style="font-size:14.0pt"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">Note</span></b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">:
<u>Registration is not required</u>. The phone line and Internet link will be live 30 minutes before the start of the event.</span><span style="font-size:14.0pt"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">Additional information:
</span></b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">The NOFO is available on the SAMHSA website at
</span><u><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:#467886"><a href="https://www.samhsa.gov/grants/grant-announcements/ti-25-005">https://www.samhsa.gov/grants/grant-announcements/ti-25-005</a></span></u><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">.</span><span style="font-size:14.0pt"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">Applicants with programmatic questions should contact Hep C Free staff via e-mail at
</span><u><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:#467886"><a href="mailto:HepCFree@samhsa.hhs.gov">HepCFree@samhsa.hhs.gov</a></span></u><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black"> and, for budget
or grants management questions, contact </span><u><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:#467886"><a href="mailto:FOACSAT@samhsa.hhs.gov">FOACSAT@samhsa.hhs.gov</a></span></u><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black">.</span><span style="font-size:14.0pt"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:black"> <o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:16.0pt;font-family:"Calibri Light",sans-serif;color:#008FC5">Zakiya Grubbs, MPH</span></b><span style="font-size:14.0pt"><o:p></o:p></span></p>
<p style="background:white"><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:#404040">Senior Manager, Hepatitis</span><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:#201F1E"> </span><span style="font-size:14.0pt"><o:p></o:p></span></p>
<p style="background:white"><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:#404040">Pronouns: She/Her/Hers</span><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:#201F1E"> </span><span style="font-size:14.0pt"><o:p></o:p></span></p>
<p style="background:white"><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:#201F1E">(202) 897-0081 |<b> </b></span><u><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:blue"><a href="mailto:zgrubbs@NASTAD.org">zgrubbs@NASTAD.org</a></span></u><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:#201F1E"> </span><span style="font-size:14.0pt"><o:p></o:p></span></p>
<p style="background:white"><b><span style="font-size:14.0pt;font-family:"Calibri",sans-serif;color:#008FC5">NASTAD</span></b><span style="font-size:14.0pt"><o:p></o:p></span></p>
<div class="MsoNormal" align="center" style="text-align:center"><span style="font-size:12.0pt;font-family:"Verdana",sans-serif;color:black">
<hr size="1" width="100%" align="center">
</span></div>
<p class="MsoNormal" align="center" style="text-align:center"><span style="font-size:12.0pt;font-family:"Verdana",sans-serif;color:black"><o:p> </o:p></span></p>
<p><span style="font-size:14.0pt">Good afternoon,<o:p></o:p></span></p>
<p><span style="font-size:14.0pt">Join us on </span><span style="font-size:14.0pt;font-family:"Helvetica",sans-serif;color:#232333;letter-spacing:.3pt">July 24, 2025 at 2:00 PM Eastern Time</span><span style="font-size:14.0pt"> for a webinar focused on
<i>best practices for creating and sustaining low-barrier housing options</i> for people who use drugs and other vulnerable populations. We’ll explore effective housing models, stigma-reduction strategies, and ways to build landlord and devel<a name="nhahc"></a>oper
engagement. <b>Register for the webinar <a href="https://nastad.zoom.us/meeting/register/8Z5fyCe3Rw27THMQObEDtw">
here</a>.</b> <o:p></o:p></span></p>
<p><b><span style="font-size:14.0pt">Panelists:</span></b><span style="font-size:14.0pt"><o:p></o:p></span></p>
<ul type="disc">
<li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l0 level1 lfo4">
<span style="font-size:14.0pt">Devin McEnry, <a href="https://centralcityconcern.org/">
Central City Concern</a> <b>(Portland, OR) </b><o:p></o:p></span></li><li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l0 level1 lfo4">
<span style="font-size:14.0pt">Tanesha Seaborn, <a href="https://thehousingcenter.org/">
The Housing Center</a> <b>(Cleveland, OH)</b><o:p></o:p></span></li></ul>
<p><b><span style="font-size:14.0pt">Have Questions?</span></b><span style="font-size:14.0pt"><br>
We invite you to submit questions, by Monday July 21<sup>st</sup> to help guide the discussion! Email questions to
<a href="mailto:joy@nhahc.org">joy@nhahc.org</a> <o:p></o:p></span></p>
<p><span style="font-size:14.0pt">Don’t miss this opportunity to gain tools, insight, and strategies to strengthen housing access and stability for those most in need.<o:p></o:p></span></p>
<p><span style="font-size:14.0pt">Thank you,<o:p></o:p></span></p>
<p><span style="font-size:14.0pt">Juan</span><span style="font-family:"Verdana",sans-serif;color:black"><o:p></o:p></span></p>
<div class="MsoNormal" align="center" style="text-align:center"><span style="font-size:12.0pt;font-family:"Verdana",sans-serif;color:black">
<hr size="1" width="100%" align="center">
</span></div>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><b><span style="font-size:12.0pt;font-family:"Tahoma",sans-serif;mso-ligatures:none">STI/HIV Program Director Orientation for Rural Areas</span></b><span style="font-size:10.0pt;font-family:"Tahoma",sans-serif;mso-ligatures:none"><o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span style="font-size:12.0pt;font-family:"Tahoma",sans-serif;mso-ligatures:none">N<a name="naccho"></a>ACCHO is launching a training and mentorship program for new and emerging
program leaders responsible for STD/HIV programs. This orientation is ONLY for individuals with less than two years of experience who work in rural, local, or tribal health departments - this is defined as serving populations of less than 99,000. The orientation
is a free, in-person, 1.5-day meeting from September 15 (full day) through September 16, 2025 (half day) in Minneapolis, Minnesota.</span><span style="font-size:10.0pt;font-family:"Tahoma",sans-serif;mso-ligatures:none"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:"Tahoma",sans-serif;mso-ligatures:none">If you are interested in participating, please complete
<a href="https://naccho.mmsend.com/link.cfm?r=XUONXfuMn9Hp2yl0d3ZG3g~~&pe=XwPRRo2qbMHciF79aQ6nDrFqQ8-WcTXI2WnmbTHeClmZGRezUM74Mp_jHBAV7hzR5zorrIOWSrujv1SyBAufag~~&t=Q-kYmJ4801WoAKjfMQVa5w~~" target="_blank">
<span style="color:blue">this form</span></a> by July 31, 2025. Space is limited, and selection will consider the burden of disease, years of experience, and geographic diversity.</span><span style="font-size:12.0pt;font-family:"Verdana",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal" align="center" style="text-align:center"><span style="font-size:12.0pt;font-family:"Verdana",sans-serif;color:black"><o:p> </o:p></span></p>
<div class="MsoNormal" align="center" style="text-align:center"><span style="font-size:12.0pt;font-family:"Verdana",sans-serif;color:black">
<hr size="1" width="100%" align="center">
</span></div>
<p class="MsoNormal"><span style="font-size:13.5pt;font-family:"Segoe UI",sans-serif;color:black;background:white"><o:p> </o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:14.0pt;color:black"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:14.0pt;color:black">Shelley Pearson</span></b><b><span style="font-size:14.0pt;color:black;mso-ligatures:none"><o:p></o:p></span></b></p>
<p class="MsoNormal"><i><span style="font-size:14.0pt;color:black">Pronouns: she/her/hers
<o:p></o:p></span></i></p>
<p class="MsoNormal"><span style="font-size:14.0pt;color:black">HIV/STI Administrative and Communications Specialist<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:14.0pt;color:black">OREGON HEALTH AUTHORITY
<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:14.0pt;color:black">Public Health Division<o:p></o:p></span></p>
<p class="MsoNormal"><a href="mailto:shelley.m.pearson@dhsoha.state.or.us"><span style="font-size:14.0pt;color:#0563C1">shelley.m.pearson@oha.oregon.gov</span></a><span style="font-size:14.0pt;color:black">
<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:14.0pt;color:black">Phone: 503-381-6173<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:14.0pt;color:black">Fax: 971-673-0178<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:"Calibri",sans-serif;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><a href="http://www.endhivoregon.org/"><span style="color:#0563C1;mso-ligatures:none;text-decoration:none"><img border="0" width="132" height="101" style="width:1.375in;height:1.052in" id="Picture_x0020_1" src="cid:image001.png@01DBF6F6.E6066C90"></span></a><u><span style="color:#0563C1"><o:p></o:p></span></u></p>
<p class="MsoNormal"><span style="font-family:"Calibri",sans-serif;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
</body>
</html>